Key facts
- This page summarizes Michael Moore's Form 4 filing for VIEMED HEALTHCARE, INC. (VMD).
- 2 reported transactions and 2 derivative rows are listed below.
- Accepted by SEC: 30 Jan 2024, 17:51.
Michael Moore - 29 Jan 2024 Form 4 Insider Report for VIEMED HEALTHCARE, INC. (VMD)
- Reporting relationship
- President
- Issuer ticker
- VMD
- Reported as of
- 29 Jan 2024
- Net transaction value
- $0
- SEC form
- 4
- Accepted by SEC
- 30 Jan 2024, 17:51:37 UTC
- Prior SEC filing
- 26 Jan 2024
- Next SEC filing
- 10 May 2024
- Source filing
- View source filing
- Reporting owner signature
- /s/ Jesse Bergeron, Attorney-in-Fact
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
Michael Moore filed Form 4 for VIEMED HEALTHCARE, INC. (VMD) on 30 Jan 2024.
Change
- Previous filing in this sequence was filed on 26 Jan 2024.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
VMD
transaction
Derivative
Phantom Share Units
Award
- Transaction value
- $0
- Shares
- +26,842
- Change %
- Price
- $0.000000
- Shares after
- 26,842
- Date
- 29 Jan 2024
- Ownership
- Direct
- Underlying class
- Common Shares
- Underlying amount
- 26,842
- Exercise price
- Footnotes
- F1, F2
VMD
transaction
Derivative
Restricted Stock Units
Award
- Transaction value
- $0
- Shares
- +80,527
- Change %
- Price
- $0.000000
- Shares after
- 80,527
- Date
- 29 Jan 2024
- Ownership
- Direct
- Underlying class
- Common Shares
- Underlying amount
- 80,527
- Exercise price
- Footnotes
- F3, F4
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 4 footnotes
Footnote F1
Each phantom share represents a right to receive the cash value of one share of the Issuer's common shares which will be determined based on the Issuer's share price on the vesting date.
Footnote F2
Represents an award granted on January 29, 2024 under the Issuer's Phantom Share Unit Plan which vests in three equal annual installments beginning on the first anniversary of the grant date.
Footnote F3
Each Restricted Stock Unit (RSU) represents a contingent right to receive one common share.
Footnote F4
Restricted Stock Units (RSUs) granted to reporting person on January 29, 2024, which vest in three equal annual installments beginning on the first anniversary of the grant date.